Back to Journals » Blood and Lymphatic Cancer: Targets and Therapy » Volume 10

Review

Evaluating Blinatumomab for the Treatment of Relapsed/Refractory ALL: Design, Development, and Place in Therapy

       
Total article views   HTML views PDF downloads Totals
6,265 Dovepress* 6,265+ 1,048 7,313
Totals 6,265 1,048 7,313
*Since 3 November 2020
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 0 2

View citations on Google Scholar